Korro Bio announced the appointment of Rachel Meyers, PhD, to the Company’s Board of Directors. Most recently, Dr. Meyers served as Chief Scientific Officer of Faze Medicines.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on KRRO:
- Is FREQ a Buy, Before Earnings?
- Korro Bio Inc trading resumes
- Korro Bio Inc trading halted, volatility trading pause
- Plug Power downgraded, Arm initiated: Wall Street’s top analyst calls
- Korro Bio initiated with an Overweight at Piper Sandler
Questions or Comments about the article? Write to editor@tipranks.com